Evaluating the clinical and cost-effectiveness of a conservative approach to oxygen therapy for invasively ventilated adults in intensive care: Protocol for the UK-ROX trial

Daniel S. Martin^*, Tasnin Shahid, Doug W. Gould, Alvin Richards-Belle, James C. Doidge, Julie Camsooksai, Walton N. Charles, Miriam Davey, Amelia Francis Johnson, Roger M. Garrett, Michael P.W. Grocott, Joanne Jones, Lamprini Lampro, Lorna Miller, B. Ronan O’Driscoll, Anthony J. Rostron, Zia Sadique, Tamas Szakmany, Paul J. Young, Kathryn M. RowanDavid A. Harrison, Paul R. Mouncey

^*Corresponding author for this work

Peninsula Medical School

Intensive Care National Audit and Research Centre
Maidstone and Tunbridge Wells NHS Trust
Patient and public representative
NIHR Southampton Biomedical Research Centre
Salford Royal Hospital
South Tyneside and Sunderland NHS Foundation Trust
London School of Hygiene and Tropical Medicine
Aneurin Bevan Health Board
Capital & Coast District Health Board
Medical Research Institute of New Zealand
Monash University
University of Melbourne
University Hospitals Plymouth NHS Trust

Research output: Contribution to journal › Article › peer-review

15 Downloads (Pure)

Sort by
Weight
Alphabetically

Evaluating the clinical and cost-effectiveness of a conservative approach to oxygen therapy for invasively ventilated adults in intensive care: Protocol for the UK-ROX trial

Fingerprint

Nursing and Health Professions

Medicine and Dentistry